The Mould War: Developing an Armamentarium against Fungal Pathogens Utilising Thymoquinone, Ocimene, and Miramistin within Bacterial Cellulose Matrices

An increase in antifungal resistance has seen a surge in fungal wound infections in patients who are immunocompromised resulting from chemotherapy, disease, and burns. Human pathogenic fungi are increasingly becoming resistant to a sparse repertoire of existing antifungal drugs, which has given rise to the need to develop novel treatments for potentially lethal infections. Bacterial cellulose (BC) produced by Gluconacetobacter xylinus has been shown to possess many properties that make it innately useful as a next-generation biopolymer to be utilised as a wound dressing. The current study demonstrates the creation of a pharmacologically active wound dressing by loading antifungal agents into a biopolymer hydrogel to produce a novel wound dressing. Amphotericin B is known to be highly hepatotoxic, which reduces its appeal as an antifungal drug, especially in patients who are immunocompromised. This, coupled with an increase in antifungal resistance, has seen a surge in fungal wound infections in patients who are immunodeficient due to chemotherapy, disease, or injury. Antifungal activity was conducted via Clinical & Laboratory Standards Institute (CLSI) M27, M38, M44, and M51 against Candida auris, Candida albicans, Aspergillus fumigatus, and Aspergillus niger. This study showed that thymoquinone has a comparable antifungal activity to amphotericin B with mean zones of inhibition of 21.425 ± 0.925 mm and 22.53 ± 0.969 mm, respectively. However, the mean survival rate of HEp-2 cells when treated with 50 mg/L amphotericin B was 29.25 ± 0.854% compared to 71.25 ± 1.797% when treated with 50 mg/L thymoquinone. Following cytotoxicity assays against HEp-2 cells, thymoquinone showed a 71.25 ± 3.594% cell survival, whereas amphotericin B had a mean cell survival rate of 29.25 ± 1.708%. The purpose of this study was to compare the efficacy of thymoquinone, ocimene, and miramistin against amphotericin B in the application of novel antifungal dressings.

[1]  R. Summerbell,et al.  The increasing problem of treatment‐resistant fungal infections: a call for antifungal stewardship programs , 2021, International journal of dermatology.

[2]  C. Hughes,et al.  Development of a core outcome set for clinical trials aimed at improving antimicrobial stewardship in care homes , 2021, Antimicrobial resistance and infection control.

[3]  R. A. Ilyas,et al.  Characterization of compressed bacterial cellulose nanopaper film after exposure to dry and humid conditions , 2021, Journal of Materials Research and Technology.

[4]  D. Sahoo,et al.  Antifungal activity and volatile organic compounds analysis of essential oils from Cymbopogon species using solid-phase microextraction-gas chromatography-mass spectrometry , 2021 .

[5]  Jaclyn M. Winter,et al.  Antifungal natural products. , 2021, Current opinion in biotechnology.

[6]  F. Queiroz-Telles,et al.  Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections , 2021, Infectious Diseases and Therapy.

[7]  M. Cavaleri,et al.  Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight? , 2021, Antimicrobial resistance and infection control.

[8]  M. Kowalczuk,et al.  Recent Advances and Applications of Bacterial Cellulose in Biomedicine , 2021, Polymers.

[9]  S. Paul,et al.  Rapid detection of ERG11 polymorphism associated azole resistance in Candida tropicalis. , 2021, PloS one.

[10]  J. Pemán,et al.  Antifungal Resistance among Less Prevalent Candida Non-albicans and Other Yeasts versus Established and under Development Agents: A Literature Review , 2021, Journal of fungi.

[11]  O. Singh,et al.  Formulation, characterization and in vitro anti-leishmanial evaluation of amphotericin B loaded solid lipid nanoparticles coated with vitamin B12-stearic acid conjugate. , 2020, Materials science & engineering. C, Materials for biological applications.

[12]  P. van Dijck,et al.  Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance , 2020, Journal of fungi.

[13]  M. Hoenigl,et al.  Breakthrough invasive fungal infections: Who is at risk? , 2020, Mycoses.

[14]  L. Applegate,et al.  Potency and stability of liposomal Amphotericin B formulated for topical management of Aspergillus spp. infections in burn patients , 2020, Burns Open.

[15]  D. Denning,et al.  The antiseptic Miramistin: a review of its comparative in vitro and clinical activity. , 2020, FEMS microbiology reviews.

[16]  E. Nweze,et al.  Mechanism of Candida pathogenesis: revisiting the vital drivers , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[17]  R. Walia,et al.  Updates in the Treatment of Breakthrough Mold Infections , 2020, Current Fungal Infection Reports.

[18]  S. Mecozzi,et al.  Preparation, Characterization, and Formulation Optimization of Ionic Liquid-in-Water Nanoemulsions towards Systemic Delivery of Amphotericin B. , 2020, Molecular pharmaceutics.

[19]  M. Edirisinghe,et al.  Bacterial cellulose micro-nano fibres for wound healing applications. , 2020, Biotechnology advances.

[20]  K. Wasan.  Development of an Oral Amphotericin B Formulation as an Alternative Approach to Parenteral Amphotericin B Administration in the Treatment of Blood-Borne Fungal Infections. , 2020, Current pharmaceutical design.

[21]  G. Thompson,et al.  Aspiring Antifungals: Review of Current Antifungal Pipeline Developments , 2020, Journal of fungi.

[22]  M. Legrand,et al.  Outcome and characteristics of invasive fungal infections in critically ill burn patients: A multicenter retrospective study , 2020, Mycoses.

[23]  K. Balakin,et al.  Antibacterial activity profile of miramistin in in vitro and in vivo models. , 2020, Microbial pathogenesis.

[24]  C. Nicolae,et al.  Bacterial cellulose sponges obtained with green cross-linkers for tissue engineering. , 2020, Materials science & engineering. C, Materials for biological applications.

[25]  G. Adamus,et al.  Synthesis of Silver Nanoparticles Using Curcumin-Cyclodextrins Loaded into Bacterial Cellulose-Based Hydrogels for Wound Dressing Applications , 2020, Biomacromolecules.

[26]  W. Hua,et al.  Chemical compositions, yield variations and antimicrobial activities of essential oils from three species of Euodiae Fructus in China , 2019, Industrial Crops and Products.

[27]  G. Luo,et al.  Candidemia in major burn patients and its possible risk factors: A 6-year period retrospective study at a burn ICU. , 2019, Burns : journal of the International Society for Burn Injuries.

[28]  Rushikesh S. Ambekar,et al.  Advancements in nanofibers for wound dressing: A review , 2019, European Polymer Journal.

[29]  S. Ramakrishna,et al.  Wound dressings: Current advances and future directions , 2019, Journal of Applied Polymer Science.

[30]  D. Denning,et al.  In vitro and in vivo efficacy of miramistin against drug-resistant fungi. , 2019, Journal of medical microbiology.

[31]  A. Baker,et al.  Therapeutic strategies for enhancing angiogenesis in wound healing. , 2019, Advanced drug delivery reviews.

[32]  António Pedro Souto,et al.  Development of novel bacterial cellulose composites for the textile and shoe industry , 2019, Microbial biotechnology.

[33]  C. d’Enfert,et al.  Studying fungal pathogens of humans and fungal infections: fungal diversity and diversity of approaches , 2019, Genes & Immunity.

[34]  C. d’Enfert,et al.  Studying fungal pathogens of humans and fungal infections: fungal diversity and diversity of approaches. , 2019, Microbes and infection.

[35]  B. Ford,et al.  Angioinvasive fungal infections impacting the skin: Background, epidemiology, and clinical presentation. , 2019, Journal of the American Academy of Dermatology.

[36]  B. Ford,et al.  Angioinvasive fungal infections impacting the skin: Diagnosis, management, and complications. , 2019, Journal of the American Academy of Dermatology.

[37]  A. Que,et al.  Infection of burn wound by Aspergillus fumigatus with gross appearance of fungal colonies , 2019, Medical mycology case reports.

[38]  C. R. Leal,et al.  Bacterial cellulose: a versatile biopolymer for wound dressing applications , 2019, Microbial biotechnology.

[39]  D. Uglanov,et al.  A Study of the Physical and Mechanical Properties of Aerogels Obtained from Bacterial Cellulose. , 2019, Biomacromolecules.

[40]  H. Younus,et al.  Therapeutic potential of thymoquinone liposomes against the systemic infection of Candida albicans in diabetic mice , 2018, PloS one.

[41]  D. Prosvirnikov,et al.  Microcrystalline Cellulose Based on Cellulose Containing Raw Material Modified by Steam Explosion Treatment , 2018, Solid State Phenomena.

[42]  R. Du,et al.  Production, Optimization and Partial Characterization of Bacterial Cellulose from Gluconacetobacter xylinus TJU-D2 , 2018, Waste and Biomass Valorization.

[43]  S. Britland,et al.  Physicochemical characterisation of biosynthetic bacterial cellulose as a potential wound dressing material , 2018, British Journal of Pharmacy.

[44]  T. Volova,et al.  Production and properties of bacterial cellulose by the strain Komagataeibacter xylinus B-12068 , 2018, Applied Microbiology and Biotechnology.

[45]  H. Shaterzadeh-Yazdi,et al.  An Overview on Renoprotective Effects of Thymoquinone , 2018, Kidney Diseases.

[46]  Chandragouda R. Patil,et al.  Therapeutic Potential and Pharmaceutical Development of Thymoquinone: A Multitargeted Molecule of Natural Origin , 2017, Front. Pharmacol..

[47]  M. Gad,et al.  In Vitro Evaluation of the Inhibitory Activity of Thymoquinone in Combatting Candida albicans in Denture Stomatitis Prevention , 2017, International journal of environmental research and public health.

[48]  Ousman Deke Pierre Alexis,et al.  New Approach for Skin Repair by Using Bacterial Cellulose Altered with Paraffin and Porous Bacterial Cellulose based Scaffold with Alginate , 2017 .

[49]  N. Gow,et al.  Candida albicans Yeast, Pseudohyphal, and Hyphal Morphogenesis Differentially Affects Immune Recognition , 2017, Front. Immunol..

[50]  S. Vitta,et al.  Bacterial cellulose based flexible multifunctional nanocomposite sheets , 2017, Cellulose.

[51]  S. Britland,et al.  Characterisation and in vitro antimicrobial activity of biosynthetic silver-loaded bacterial cellulose hydrogels , 2016, Journal of microencapsulation.

[52]  Changshun Ruan,et al.  Effect of cellulose crystallinity on bacterial cellulose assembly , 2016, Cellulose.

[53]  L. Salgueiro,et al.  Antifungal activity of the essential oil of Angelica major against Candida, Cryptococcus, Aspergillus and dermatophyte species , 2015, Journal of Natural Medicines.

[54]  M. Gondal,et al.  Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm , 2015, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering.

[55]  Y. Huang,et al.  Recent advances in bacterial cellulose , 2014, Cellulose.

[56]  R. Giugliani,et al.  Cytotoxic effect of amphotericin B in a myofibroblast cell line. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[57]  M. AbuKhader.  Thymoquinone in the clinical treatment of cancer: Fact or fiction? , 2013, Pharmacognosy reviews.

[58]  J. Pemán,et al.  Antifungal Susceptibility Testing of Filamentous Fungi , 2012, Current Fungal Infection Reports.

[59]  Y. Wan,et al.  Preparation and characterization of bacterial cellulose sponge with hierarchical pore structure as tissue engineering scaffold , 2011 .

[60]  J. Oddershede,et al.  On the determination of crystallinity and cellulose content in plant fibres , 2005 .

[61]  P. Stephens,et al.  Crystal structure determination of thymoquinone by high-resolution X-ray powder diffraction , 2004, AAPS PharmSciTech.

[62]  A. Bauer,et al.  Antibiotic susceptibility testing by a standardized single disk method. , 1966, American journal of clinical pathology.

[63]  M. K. Hussain,et al.  Bio-active Compounds Isolated from Neem Tree and Their Applications , 2019, Natural Bio-active Compounds.

[64]  S. Chourasia,et al.  Disseminated invasive Aspergillosis in a case of fatal antemortem flame burns , 2019, Journal of Indian Academy of Forensic Medicine.

[65]  M. Khan.  Antimicrobial Action of Thymoquinone , 2018 .

[66]  H. Younus.  Molecular and Therapeutic actions of Thymoquinone , 2018, Springer Singapore.

[67]  F. Echavarría-Cháirez,et al.  Chemical composition and FTIR of ethane extracts of Larrea tridentata, Origanum vulgare, Artemisa ludoviciana and Ruta graveolens. , 2018 .

[68]  I. Macreadie,et al.  Fungicidal effect of thymoquinone involves generation of oxidative stress in Candida glabrata. , 2017, Microbiological research.

[69]  J. Marcu,et al.  Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads. , 2017, Advances in pharmacology.

[70]  D. Enoch,et al.  The Changing Epidemiology of Invasive Fungal Infections. , 2017, Methods in molecular biology.

[71]  M. Darweesh,et al.  Efficacy of Thymoquinone against Vaginal Candidiasis in Prednisolone-induced Immunosuppressed Mice , 2013 .

[72]  M. Farrington,et al.  Chapter 14 – Chemotherapy of bacterial infections , 2012 .

[73]  P. Eckl,et al.  In vitro toxicological properties of thymoquinone. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[74]  John H. Rex,et al.  Method for antifungal disk diffusion susceptibility testing of yeasts : Approved guideline , 2009 .